Process not transferable during validation planning – ICH Q8/Q11 alignment strategy


Published on 25/04/2026

Managing Non-Transferable Processes During Validation: An ICH Q8/Q11 Playbook

In the realm of pharmaceutical manufacturing, the alignment of development processes during validation can be a significant challenge. This issue often manifests itself when processes that worked flawlessly in small-scale formulations fail to transfer to full-scale production. Understanding and addressing the reasons behind this failure is critical for maintaining compliance and ensuring product quality.

This comprehensive playbook provides actionable insights for professionals in production, quality control, quality assurance, engineering, and regulatory affairs. After reading this article, you will be equipped to identify symptoms, investigate causes, and implement controls to ensure that processes are effectively transferred and validated during scaling operations.

Symptoms/Signals on the Floor or in the Lab

Detecting early signals of process transfer issues is essential for minimizing risk. Here are common symptoms observed in both production and lab environments:

  • Out-of-Specification (OOS) Results: Any deviations from expected physicochemical properties, such as pH, potency, or dissolution rates, should be closely monitored.
  • Increased Variability:
A notable spike in batch-to-batch variability signals potential underlying transfer issues in formulation or process parameters.
  • Equipment Misalignment: Instances of equipment malfunction or miscalibration during scale-up can disrupt process consistency.
  • Extended Processing Times: Unexplained increases in production cycle times suggest inefficiencies that may not have been present at the pilot scale.
  • Quality Control Failures: Frequent rejection of batches during QC testing indicates problems stemming from the scale-up process.
  • Likely Causes

    When evaluating the reasons for non-transferable processes during validation planning, identifying categories of potential causes aids in developing targeted interventions:

    Category Likely Causes
    Materials Variability in raw materials or suppliers affecting consistency.
    Method Inconsistent SOPs or deviations from established validation protocols.
    Machine Different equipment efficiencies or settings during scale-up.
    Man Training gaps or human errors during operation.
    Measurement Inaccurate analytical methods leading to poor data interpretation.
    Environment Uncontrolled environmental variables affecting process conditions.

    Immediate Containment Actions (first 60 minutes)

    Upon identifying symptoms of non-transferability, swift action is required to minimize repercussions:

    1. Stop Production: Immediately halt operations to prevent further deviations or quality issues.
    2. Isolate Affected Batches: Secure any affected products to prevent release.
    3. Alert Stakeholders: Notify team leaders in production, QA, and regulatory departments.
    4. Initial Assessment: Gather preliminary data about the issue including batch records and QC results.
    5. Assign Roles: Designate investigation teams to focus on specific categories of likely causes.

    Investigation Workflow

    An effective investigation is rooted in data collection and analysis. Follow these steps to facilitate a comprehensive investigation:

    1. Collect Relevant Data: Gather batch records, equipment logs, process parameters, and QC test results.
    2. Assess Regulatory Requirements: Verify adherence to ICH Q8/Q11 guidelines regarding process validation.
    3. Interview Personnel: Conduct discussions with operators and technicians to understand operational nuances.
    4. Analyze Environmental Conditions: Document ambient conditions during production to identify any anomalies.

    This data will serve as the foundation for understanding the issues impacting process transferability.

    Root Cause Tools

    Utilize established root cause analysis techniques to identify underlying issues:

    • 5-Why Analysis: Use this technique for straightforward problems where asking “why” multiple times leads to uncovering root causes.
    • Fishbone Diagram: Ideal for complex problems with multiple contributing factors. Categorize causes into groups such as Man, Machine, Method, etc.
    • Fault Tree Analysis: Useful for quantifying risk for manufacturing failures requiring a detailed dive into failure mechanisms.

    When selecting the right tool, consider the complexity of the issue and the resources available for investigation.

    CAPA Strategy

    A robust Corrective and Preventive Action (CAPA) strategy is critical in addressing identified issues to prevent recurrence:

    • Correction: Implement immediate fixes to the current process, ensuring that affected batches are re-evaluated correctly.
    • Corrective Action: Modify processes, update SOPs, and enhance training programs based on root cause findings.
    • Preventive Action: Develop a long-term strategy, including monitoring plans and risk assessments to mitigate future issues.

    Control Strategy & Monitoring

    An effective control strategy must be established to monitor processes and ensure compliance:

    • Statistical Process Control (SPC): Implement SPC tools to monitor critical parameters and identify trends that could indicate potential issues.
    • Sampling Plans: Regularly review sampling frequency and techniques to ensure consistent product quality.
    • Alarms & Alerts: Install alarm systems for critical process parameters to prompt immediate investigations if they are breached.
    • Verification: Verify and validate processes on an ongoing basis, ensuring they continually meet predefined specifications.

    Validation / Re-qualification / Change Control impact

    Each of the steps discussed in this playbook can have downstream effects on your validation efforts:

    • Validation Impact: Systems impacted by non-transferability may require full validation re-assessment to confirm compliance.
    • Re-qualification Needs: If significant changes to processes arise, a requalification may be warranted to maintain trust and quality.
    • Change Control: Adhere to a strict change control process when implementing corrections or modifications to processes to ensure documented accountability.

    Inspection Readiness: What Evidence to Show

    Prepare for inspections by ensuring all documentation is complete, accurate, and readily available:

    Related Reads

    • Records & Logs: Maintain meticulous production logs and equipment calibration records.
    • Batch Documentation: Ensure batch records are complete and reflect any deviations or investigations conducted.
    • Deviations: Document all deviations from established processes and the resulting CAPA measures taken.
    • Change Controls: Keep a well-organized repository of all change control documents related to process adjustments.

    FAQs

    What are the key indicators of process non-transferability?

    Common indicators include out-of-specification results, increased variability, and extended processing times.

    How can I implement immediate containment actions?

    Stop production, isolate affected batches, alert stakeholders, and conduct an initial assessment within the first hour.

    What root cause analysis tools should I use?

    Utilize 5-Why analysis for straightforward issues, Fishbone diagrams for complex problems, and Fault Tree Analysis for quantifying risks.

    How do I prepare for regulatory inspections?

    Ensure all records, logs, batch documentation, and deviation reports are accurate, complete, and readily accessible to inspectors.

    What is the difference between corrective and preventive actions?

    Corrective actions address existing issues, while preventive actions are designed to avoid recurrence in the future.

    How does change control relate to process validation?

    Change control ensures that any modifications to processes are systematically reviewed and documented, maintaining compliance and quality.

    What forms of data should be collected during an investigation?

    Collect batch records, equipment logs, QC results, and environmental conditions for a thorough analysis.

    Why is monitoring critical to the control strategy?

    Monitoring provides real-time insights into process performance and alerts teams to deviations before they lead to significant issues.

    When should validation or re-qualification occur?

    Validation or re-qualification should occur after significant changes to the process or when transfer issues are identified, to ensure compliance.

    What regulatory guidelines should I consider?

    Key guidelines include ICH Q8 and Q11 relating to process validation and quality by design principles.

    How can SPC be effectively implemented?

    SPC can be implemented by defining critical parameters, setting control limits, and regularly monitoring trends in manufacturing data.

    What documents are crucial for inspection readiness?

    Crucial documents include production records, SOPs, deviation logs, attribution of CAPAs, and change control documentation.

    Pharma Tip:  CPPs not well defined during regulatory submission – regulatory scrutiny risk